Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5689-5695, October 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyake, M.
Right arrow Articles by Hakomori, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyake, M.
Right arrow Articles by Hakomori, S.-i.

Human IgG3 Monoclonal Antibody Directed to an Unbranched Repeating Type 2 Chain (Galß1->4GlcNAcß1->3Galß1->4GlcNAcß1->3Galß1->R) Which Is Highly Expressed in Colonic and Hepatocellular Carcinoma1

Masayuki Miyake2, Nobuoki Kohno2, Edward D. Nudelman and Sen-itiroh Hakomori

The Biomembrane Institute and University of Washington, 201 Elliott Avenue West, Seattle, Washington

Previously established human monoclonal antibodies (MAbs) directed to carbohydrate antigens are essentially all IgM class, and show relatively low affinity and low reactivity at 37°C. We report here the establishment of a human IgG3 MAb displaying high affinity antigen-binding activity at 37°C and efficiently activating cellular cytotoxicity directed to human tumor cell lines expressing the polylactosamine antigen. The IgG3 MAb (MH21–134) reacted with the repeated unbranched polylactosamine structure Galß1->4GlcNAcß1->3Galß1->4GlcNAcß1->3Galß1->R, i.e., nLc6, nLc8, etc., but did not react with sialyl 2->3 or 2->6 substituted derivatives at the terminal Gal. This specificity differs from that of several anti-i antibodies, or human anti-i-like MAbs which react with sialyl 2->3 substituted structures. Directly biotinylated MH21–134 antibody was used in immunohistochemical staining of 154 formalin-fixed, paraffin-embedded tissue sections to study distribution of the antigen. High incidence of positive staining was found in colon cancer (11/17; 65%) and hepatocellular carcinoma (8/12; 67%), followed by large cell and squamous cell carcinoma of lung cancer (10/13; 59%, and 14/26; 54%, respectively). TLC immunostaining of glycolipid extracts from a variety of tumor tissues showed the presence of nLc6 and/or nLc8 in over 50% of cases. The antigens nLc6 and nLc8 were found to be absent from normal colonic epithelia, kidney, and pancreas. Only a weak band corresponding to nLc8 and one corresponding to nLc6 were found in liver and spleen, although all these normal tissues, including gastrointestinal epithelia, lung, liver, spleen, erythrocytes, and lymphocytes, were essentially negative on immunohistology. However, the antigen was found to be highly expressed in myelocytes and weakly in bronchial glands of lung and pancreatic duct epithelia. Nevertheless, expression of unsubstituted, unbranched polylactosamine antigen could be an important basis for induction of humoral immune response against certain types of human cancer, despite its limited expression in normal cells.

1 This study was supported by funds from The Biomembrane Institute and in part by Outstanding Investigator Grant (OIG) CA42505 from the National Cancer Institute.

2 Senior Fellow, Department of Pathobiology, University of Washington, and The Biomembrane Institute.

Received 1/30/89. Revised 6/29/89. Accepted 7/13/89.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y.-Y. Fan, S.-Y. Yu, H. Ito, A. Kameyama, T. Sato, C.-H. Lin, L.-C. Yu, H. Narimatsu, and K.-H. Khoo
Identification of Further Elongation and Branching of Dimeric Type 1 Chain on Lactosylceramides from Colonic Adenocarcinoma by Tandem Mass Spectrometry Sequencing Analyses
J. Biol. Chem., June 13, 2008; 283(24): 16455 - 16468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Isshiki, T. Kudo, S. Nishihara, Y. Ikehara, A. Togayachi, A. Furuya, K. Shitara, T. Kubota, M. Watanabe, M. Kitajima, et al.
Lewis Type 1 Antigen Synthase ({beta}3Gal-T5) Is Transcriptionally Regulated by Homeoproteins
J. Biol. Chem., September 19, 2003; 278(38): 36611 - 36620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.